Cantor Fitzgerald Reiterates Overweight on Eli Lilly, Maintains $630 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Eli Lilly (LLY) and maintained a price target of $630. This reaffirms the firm's positive outlook on the stock.
February 01, 2024 | 5:08 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald analyst Louise Chen reaffirmed an Overweight rating on Eli Lilly, with a price target of $630, indicating a strong bullish outlook.
The reiteration of an Overweight rating and a high price target of $630 by a reputable analyst like Louise Chen from Cantor Fitzgerald is likely to instill confidence among investors and could lead to a positive short-term impact on Eli Lilly's stock price. The analyst's bullish stance suggests a strong belief in the company's future performance.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100